Ligand Pharmaceuticals Ownership 2024 | Who Owns Ligand Pharmaceuticals Now?
Institutional Ownership
75.57%
Insider Ownership
2.14%
Retail Ownership
22.29%
Institutional Holders
174.00
Ligand Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 16.19% | 0.01% | 2,871,496 | 3,226 | 0.11% | 241,952,252 | Jun 30, 2024 |
| VANGUARD GROUP INC | 10.87% | 0.00% | 1,926,874 | 42,762 | 2.27% | 162,358,403 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 5.69% | 0.05% | 1,008,733 | 256 | 0.03% | 84,994,809 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 5.45% | 0.09% | 966,552 | -66,629 | -6.45% | 81,442,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 4.00% | 0.02% | 708,624 | 44,543 | 6.71% | 59,706,962 | Jun 30, 2024 |
| STATE STREET CORP | 3.88% | 0.00% | 688,772 | 17,488 | 2.61% | 58,035,929,000 | Jun 30, 2024 |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 3.68% | 0.77% | 652,000 | -44,758 | -6.42% | 54,937,520 | Jun 30, 2024 |
| CONGRESS ASSET MANAGEMENT CO /MA | 3.31% | 0.35% | 586,624 | 586,624 | 100.00% | 49,428,941 | Jun 30, 2024 |
| CHICAGO CAPITAL, LLC | 2.90% | 1.29% | 514,946 | 285,350 | 124.28% | 43,389,340 | Jun 30, 2024 |
| VILLERE ST DENIS J & CO LLC | 2.73% | 3.45% | 483,913 | -6,839 | -1.39% | 40,774,509 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.29% | 0.00% | 405,775 | 24,805 | 6.51% | 34,197,268 | Jun 30, 2024 |
| ASHFORD CAPITAL MANAGEMENT INC | 1.82% | 3.67% | 322,207 | 125,672 | 63.94% | 27,149,162 | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 1.65% | 1.48% | 292,475 | 12,691 | 4.54% | 24,643,944 | Jun 30, 2024 |
| IMPAX ASSET MANAGEMENT GROUP PLC | 1.58% | 0.10% | 280,208 | 25,000 | 9.80% | 23,610,326 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.52% | 0.01% | 270,224 | 34,320 | 14.55% | 22,769,074 | Jun 30, 2024 |
| ABRDN PLC | 1.52% | 0.04% | 270,143 | -11,413 | -4.05% | 22,762,249 | Jun 30, 2024 |
| LOOMIS SAYLES & CO L P | 1.46% | 0.03% | 258,343 | 258,343 | 100.00% | 21,768,000 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 1.16% | 0.00% | 204,903 | -5,383 | -2.56% | 17,265,127,000 | Jun 30, 2024 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.14% | 0.04% | 202,842 | 13,595 | 7.18% | 17,091,467 | Jun 30, 2024 |
| MORGAN STANLEY | 1.10% | 0.00% | 194,338 | -57,559 | -22.85% | 16,374,964 | Jun 30, 2024 |
Ligand Pharmaceuticals's largest institutional shareholder is BLACKROCK INC., holding 16.19% of the company's total share outstanding, currently valued at $241.95M. The top 10 institutional shareholders own together 58.70% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 1.82% | 3.67% | 322,207 | 125,672 | 63.94% | 27,149,162 | Jun 30, 2024 |
| VILLERE ST DENIS J & CO LLC | 2.73% | 3.45% | 483,913 | -6,839 | -1.39% | 40,774,509 | Jun 30, 2024 |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 0.75% | 3.08% | 133,672 | -425,563 | -76.10% | 11,263,209 | Jun 30, 2024 |
| KNOTT DAVID M JR | 0.48% | 2.86% | 85,000 | -30,000 | -26.09% | 7,162,000 | Jun 30, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.31% | 2.47% | 54,682 | - | - | 4,607,505 | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 1.65% | 1.48% | 292,475 | 12,691 | 4.54% | 24,643,944 | Jun 30, 2024 |
| PRIVATE CAPITAL MANAGEMENT, LLC | 0.76% | 1.32% | 134,505 | 134,505 | 100.00% | 11,333,391 | Jun 30, 2024 |
| CHICAGO CAPITAL, LLC | 2.90% | 1.29% | 514,946 | 285,350 | 124.28% | 43,389,340 | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.40% | 1.12% | 70,780 | 70,780 | 100.00% | 5,963,923 | Jun 30, 2024 |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 3.68% | 0.77% | 652,000 | -44,758 | -6.42% | 54,937,520 | Jun 30, 2024 |
| JACKSON CREEK INVESTMENT ADVISORS LLC | 0.08% | 0.42% | 13,600 | -24 | -0.18% | 1,146,000 | Jun 30, 2024 |
| F/M INVESTMENTS LLC | 0.76% | 0.41% | 134,710 | 134,710 | 100.00% | 11,350,204 | Jun 30, 2024 |
| RANGER INVESTMENT MANAGEMENT, L.P. | 0.39% | 0.39% | 68,395 | 16,945 | 32.93% | 5,762,963 | Jun 30, 2024 |
| ISTHMUS PARTNERS, LLC | 0.27% | 0.39% | 48,176 | -155 | -0.32% | 4,059,310 | Jun 30, 2024 |
| UNIPLAN INVESTMENT COUNSEL, INC. | 0.28% | 0.38% | 49,617 | 8,416 | 20.43% | 4,180,000 | Jun 30, 2024 |
| COURT PLACE ADVISORS, LLC | 0.08% | 0.38% | 14,208 | 6,475 | 83.73% | 1,197,166 | Jun 30, 2024 |
| CONGRESS ASSET MANAGEMENT CO /MA | 3.31% | 0.35% | 586,624 | 586,624 | 100.00% | 49,428,941 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.30% | 0.28% | 53,379 | 20,749 | 63.59% | 4,497,715 | Jun 30, 2024 |
| KINGS PATH PARTNERS LLC | 0.04% | 0.27% | 6,880 | 6,880 | 100.00% | 579,709 | Jun 30, 2024 |
| LINDEN THOMAS ADVISORY SERVICES, LLC | 0.10% | 0.22% | 17,112 | 271 | 1.61% | 1,441,857 | Jun 30, 2024 |
The largest Ligand Pharmaceuticals shareholder by % of total assets is ASHFORD CAPITAL MANAGEMENT INC. The company owns 322.21K shares of Ligand Pharmaceuticals (LGND), representing 3.67% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CONGRESS ASSET MANAGEMENT CO /MA | 3.31% | 0.35% | 586,624 | 586,624 | 100.00% | 49,428,941 | Jun 30, 2024 |
| CHICAGO CAPITAL, LLC | 2.90% | 1.29% | 514,946 | 285,350 | 124.28% | 43,389,340 | Jun 30, 2024 |
| LOOMIS SAYLES & CO L P | 1.46% | 0.03% | 258,343 | 258,343 | 100.00% | 21,768,000 | Jun 30, 2024 |
| F/M INVESTMENTS LLC | 0.76% | 0.41% | 134,710 | 134,710 | 100.00% | 11,350,204 | Jun 30, 2024 |
| PRIVATE CAPITAL MANAGEMENT, LLC | 0.76% | 1.32% | 134,505 | 134,505 | 100.00% | 11,333,391 | Jun 30, 2024 |
| ASHFORD CAPITAL MANAGEMENT INC | 1.82% | 3.67% | 322,207 | 125,672 | 63.94% | 27,149,162 | Jun 30, 2024 |
| CONGRESS WEALTH MANAGEMENT LLC / DE / | 0.50% | 0.12% | 88,250 | 88,250 | 100.00% | 7,435,941 | Jun 30, 2024 |
| NORGES BANK | 0.42% | 0.00% | 75,194 | 75,194 | 100.00% | 6,335,846 | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.40% | 1.12% | 70,780 | 70,780 | 100.00% | 5,963,923 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 4.00% | 0.02% | 708,624 | 44,543 | 6.71% | 59,706,962 | Jun 30, 2024 |
| VANGUARD GROUP INC | 10.87% | 0.00% | 1,926,874 | 42,762 | 2.27% | 162,358,403 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.52% | 0.01% | 270,224 | 34,320 | 14.55% | 22,769,074 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.26% | 0.00% | 45,869 | 30,130 | 191.44% | 3,864,920 | Jun 30, 2024 |
| TOWNSQUARE CAPITAL LLC | 0.15% | 0.03% | 26,673 | 26,673 | 100.00% | 2,247,467 | Jun 30, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | 0.45% | 0.00% | 79,612 | 25,717 | 47.72% | 6,708,107 | Jun 30, 2024 |
| IMPAX ASSET MANAGEMENT GROUP PLC | 1.58% | 0.10% | 280,208 | 25,000 | 9.80% | 23,610,326 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.29% | 0.00% | 405,775 | 24,805 | 6.51% | 34,197,268 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.30% | 0.28% | 53,379 | 20,749 | 63.59% | 4,497,715 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.52% | 0.01% | 91,464 | 18,303 | 25.02% | 7,706,754 | Jun 30, 2024 |
| STATE STREET CORP | 3.88% | 0.00% | 688,772 | 17,488 | 2.61% | 58,035,929,000 | Jun 30, 2024 |
As of Jun 30 2024, Ligand Pharmaceuticals's largest institutional buyer is CONGRESS ASSET MANAGEMENT CO /MA. The company purchased 586.62K stocks of LGND, valued at $49.43M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 0.75% | 3.08% | 133,672 | -425,563 | -76.10% | 11,263,209 | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -68,657 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 5.45% | 0.09% | 966,552 | -66,629 | -6.45% | 81,442,000 | Jun 30, 2024 |
| DANA INVESTMENT ADVISORS, INC. | 0.09% | 0.06% | 16,714 | -59,132 | -77.96% | 1,408,322 | Jun 30, 2024 |
| MORGAN STANLEY | 1.10% | 0.00% | 194,338 | -57,559 | -22.85% | 16,374,964 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.39% | 0.01% | 68,370 | -55,675 | -44.88% | 5,760,856 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.58% | 0.00% | 102,450 | -47,288 | -31.58% | 8,632,437 | Jun 30, 2024 |
| HILLSDALE INVESTMENT MANAGEMENT INC. | - | - | - | -45,032 | -100.00% | - | Jun 30, 2024 |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 3.68% | 0.77% | 652,000 | -44,758 | -6.42% | 54,937,520 | Jun 30, 2024 |
| INVESCO LTD. | 0.97% | 0.00% | 172,811 | -42,284 | -19.66% | 14,561,054 | Jun 30, 2024 |
| AMI ASSET MANAGEMENT CORP | - | - | - | -40,931 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.15% | 0.00% | 25,743 | -36,849 | -58.87% | 2,169,105 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -36,810 | -100.00% | - | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | - | -31,714 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -31,266 | -100.00% | - | Jun 30, 2024 |
| KNOTT DAVID M JR | 0.48% | 2.86% | 85,000 | -30,000 | -26.09% | 7,162,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.10% | 0.00% | 18,200 | -28,900 | -61.36% | 1,533,532 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.01% | 0.01% | 890 | -25,910 | -96.68% | 74,991 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.03% | 0.00% | 4,924 | -17,641 | -78.18% | 407,313 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.56% | 0.00% | 100,041 | -16,252 | -13.97% | 8,429,454 | Jun 30, 2024 |
As of Jun 30 2024, Ligand Pharmaceuticals's biggest institutional seller is CARDINAL CAPITAL MANAGEMENT LLC /CT. The company sold -0.43M shares of LGND, valued at $11.26M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CONGRESS ASSET MANAGEMENT CO /MA | 3.31% | 0.35% | 586,624 | 586,624 | 100.00% | 49,428,941 | Jun 30, 2024 |
| LOOMIS SAYLES & CO L P | 1.46% | 0.03% | 258,343 | 258,343 | 100.00% | 21,768,000 | Jun 30, 2024 |
| F/M INVESTMENTS LLC | 0.76% | 0.41% | 134,710 | 134,710 | 100.00% | 11,350,204 | Jun 30, 2024 |
| PRIVATE CAPITAL MANAGEMENT, LLC | 0.76% | 1.32% | 134,505 | 134,505 | 100.00% | 11,333,391 | Jun 30, 2024 |
| CONGRESS WEALTH MANAGEMENT LLC / DE / | 0.50% | 0.12% | 88,250 | 88,250 | 100.00% | 7,435,941 | Jun 30, 2024 |
| NORGES BANK | 0.42% | 0.00% | 75,194 | 75,194 | 100.00% | 6,335,846 | Jun 30, 2024 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 0.40% | 1.12% | 70,780 | 70,780 | 100.00% | 5,963,923 | Jun 30, 2024 |
| TOWNSQUARE CAPITAL LLC | 0.15% | 0.03% | 26,673 | 26,673 | 100.00% | 2,247,467 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.06% | 0.00% | 9,867 | 9,867 | 100.00% | 831,393 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 8,135 | 8,135 | 100.00% | 685,455 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.04% | 0.01% | 7,916 | 7,916 | 100.00% | 667,002 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.04% | 0.00% | 7,220 | 7,220 | 100.00% | 608,357 | Jun 30, 2024 |
| KINGS PATH PARTNERS LLC | 0.04% | 0.27% | 6,880 | 6,880 | 100.00% | 579,709 | Jun 30, 2024 |
| JANNEY CAPITAL MANAGEMENT LLC | 0.03% | 0.03% | 5,833 | 5,833 | 100.00% | 491,000 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.02% | 0.00% | 4,406 | 4,406 | 100.00% | 371,249 | Jun 30, 2024 |
| EQUITABLE TRUST CO | 0.02% | 0.02% | 4,080 | 4,080 | 100.00% | 343,781 | Jun 30, 2024 |
| SEQUOIA FINANCIAL ADVISORS, LLC | 0.02% | 0.00% | 4,029 | 4,029 | 100.00% | 339,484 | Jun 30, 2024 |
| COOKSON PEIRCE & CO INC | 0.02% | 0.01% | 3,341 | 3,341 | 100.00% | 281,513 | Jun 30, 2024 |
| PROFUND ADVISORS LLC | 0.02% | 0.01% | 3,155 | 3,155 | 100.00% | 265,840 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.02% | 0.00% | 2,956 | 2,956 | 100.00% | 249,073 | Jun 30, 2024 |
| PORTSIDE WEALTH GROUP, LLC | 0.02% | 0.04% | 2,722 | 2,722 | 100.00% | 229,356 | Jun 30, 2024 |
| ASHTON THOMAS PRIVATE WEALTH, LLC | 0.01% | 0.01% | 1,891 | 1,891 | 100.00% | 159,336 | Jun 30, 2024 |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 0.00% | 0.00% | 790 | 790 | 100.00% | 67,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | 0.00% | 536 | 536 | 100.00% | 44,129 | Jun 30, 2024 |
| CAMELOT PORTFOLIOS, LLC | 0.00% | 0.02% | 500 | 500 | 100.00% | 42,130 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.01% | 367 | 367 | 100.00% | 30,923 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 220 | 220 | 100.00% | 18,537 | Jun 30, 2024 |
| CREWE ADVISORS LLC | 0.00% | 0.00% | 207 | 207 | 100.00% | 17,442 | Jun 30, 2024 |
| OPAL WEALTH ADVISORS, LLC | 0.00% | 0.01% | 207 | 207 | 100.00% | 17,442 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 197 | 197 | 100.00% | 16,219 | Jun 30, 2024 |
| NAPLES MONEY MANAGEMENT LLC | 0.00% | 0.01% | 100 | 100 | 100.00% | 8,485 | Jun 30, 2024 |
| CAPE INVESTMENT ADVISORY, INC. | 0.00% | 0.00% | 63 | 63 | 100.00% | 5,308 | Jun 30, 2024 |
| GHP INVESTMENT ADVISORS, INC. | 0.00% | 0.00% | 57 | 57 | 100.00% | 4,803 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 43 | 43 | 100.00% | 3,624 | Jun 30, 2024 |
| STEPHENS CONSULTING, LLC | 0.00% | 0.00% | 24 | 24 | 100.00% | 2,023 | Jun 30, 2024 |
| FINANCIAL NETWORK WEALTH ADVISORS LLC | 0.00% | 0.00% | 21 | 21 | 100.00% | 1,769 | Jun 30, 2024 |
| RONALD BLUE TRUST, INC. | 0.00% | - | 19 | 19 | 100.00% | 1,389 | Jun 30, 2024 |
Ligand Pharmaceuticals's largest new institutional shareholder by number of shares is CONGRESS ASSET MANAGEMENT CO /MA, purchased 586.62K shares, valued at $49.43M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MAN GROUP PLC | - | - | - | -68,657 | -100.00% | - | Jun 30, 2024 |
| HILLSDALE INVESTMENT MANAGEMENT INC. | - | - | - | -45,032 | -100.00% | - | Jun 30, 2024 |
| AMI ASSET MANAGEMENT CORP | - | - | - | -40,931 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -36,810 | -100.00% | - | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | - | -31,714 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -31,266 | -100.00% | - | Jun 30, 2024 |
| SUMMIT GLOBAL INVESTMENTS | - | - | - | -16,171 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -14,762 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -9,121 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -9,062 | -100.00% | - | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | - | - | - | -7,000 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -6,636 | -100.00% | - | Jun 30, 2024 |
| NEBULA RESEARCH & DEVELOPMENT LLC | - | - | - | -6,300 | -100.00% | - | Jun 30, 2024 |
| JUPITER ASSET MANAGEMENT LTD | - | - | - | -5,755 | -100.00% | - | Jun 30, 2024 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | - | - | - | -5,195 | -100.00% | - | Jun 30, 2024 |
| WALLEYE TRADING LLC | - | - | - | -4,900 | -100.00% | - | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | - | - | - | -2,808 | -100.00% | - | Jun 30, 2024 |
| EVERENCE CAPITAL MANAGEMENT INC | - | - | - | -2,760 | -100.00% | - | Jun 30, 2024 |
| VESTCOR INC | - | - | - | -1,293 | -100.00% | - | Jun 30, 2024 |
| STEPHENS INC /AR/ | - | - | - | -1,094 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -897 | -100.00% | - | Jun 30, 2024 |
| QUEST PARTNERS LLC | - | - | - | -266 | -100.00% | - | Jun 30, 2024 |
| SPIRE WEALTH MANAGEMENT | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -79 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -79 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL SYNERGIES WEALTH ADVISORS, INC. | - | - | - | -13 | -100.00% | - | Jun 30, 2024 |
| AVION WEALTH | - | - | - | -9 | -100.00% | - | Jun 30, 2024 |
Ligand Pharmaceuticals's largest sold out institutional shareholder by shares sold is MAN GROUP PLC, sold -68.66K shares, valued at -, as of undefined.
Ligand Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Virtus Convertible & Income 2024 Target Term Fund | 2.68% | 5,000,000 | - | - | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 1.08% | 1,259,000 | - | - | Mar 28, 2024 |
| SPARROW FUNDS | 1.01% | 3,605 | - | - | Feb 29, 2024 |
| Delaware Enhanced Global Dividend & Income Fund | 0.82% | 301,000 | - | - | Feb 28, 2023 |
| NYSA SERIES TRUST | 0.49% | 3,000 | - | - | Jun 30, 2020 |
| DELAWARE INVESTMENTS DIVIDEND & INCOME FUND, INC | 0.33% | 87,000 | - | - | Feb 28, 2023 |
| TAX MANAGED SMALL CAP PORTFOLIO | 0.33% | 17,353 | - | - | Jan 31, 2024 |
| BUFFALO FUNDS | 0.30% | 2,000,000 | - | - | Mar 31, 2024 |
| CONESTOGA FUNDS | 0.25% | 308,390 | - | - | Mar 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.18% | 45,147 | - | - | Dec 31, 2023 |
| Gabelli Healthcare & WellnessRx Trust | 0.08% | 10,000 | - | - | Dec 29, 2023 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.07% | 209,157 | 50,000 | 31.42% | Mar 31, 2024 |
| Tema ETF Trust | 0.05% | 2,226 | - | - | Feb 29, 2024 |
| DELAWARE VIP TRUST | 0.05% | 174,000 | - | - | Mar 28, 2024 |
| ALLSPRING VARIABLE TRUST | 0.04% | 26,100 | 17,800 | 214.46% | Mar 31, 2024 |
| SPDR S&P MIDCAP 400 ETF TRUST | 0.04% | 151,174 | - | - | Mar 28, 2024 |
| REYNOLDS FUNDS INC | 0.03% | 350 | - | - | Mar 31, 2024 |
| GABELLI ASSET FUND | 0.03% | 10,000 | - | - | Dec 29, 2023 |
| Gabelli Global Small & Mid Cap Value Trust | 0.03% | 2,500 | - | - | Dec 29, 2023 |
| BNY MELLON MIDCAP INDEX FUND, INC. | 0.03% | 17,269 | - | - | Apr 30, 2022 |
| VANGUARD ADMIRAL FUNDS | 0.02% | 107,711 | 12,853 | 13.55% | Feb 29, 2024 |
| VANGUARD EXPLORER FUND | 0.02% | 302,279 | 87,425 | 40.69% | Jan 31, 2024 |
| SYNTAX ETF TRUST | 0.02% | 761 | -90 | -10.58% | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.02% | 11,225 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 11,752 | - | - | Mar 31, 2024 |
| CALVERT IMPACT FUND INC | 0.02% | 258,150 | - | - | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.02% | 18,606 | - | - | Mar 31, 2024 |
| BUFFALO FUNDS | 0.02% | 135,482 | - | - | Mar 31, 2024 |
| WASATCH FUNDS TRUST | 0.02% | 187,718 | - | - | Mar 31, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.02% | 1,297 | 1,297 | - | Sep 30, 2022 |
| ROYCE VALUE TRUST, INC. | 0.02% | 13,693 | -5,238 | -27.67% | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS V | 0.02% | 937,000 | - | - | Feb 29, 2024 |
| BNY MELLON INDEX FUNDS, INC. | 0.01% | 16,519 | -2,161 | -11.57% | Jan 31, 2024 |
| Federated Hermes MDT Series | 0.01% | 35,032 | -10,278 | -22.68% | Jan 31, 2024 |
| BNY MELLON INVESTMENT PORTFOLIOS | 0.01% | 8,230 | 109 | 1.34% | Mar 31, 2024 |
| PAX WORLD FUNDS SERIES TRUST I | 0.01% | 255,208 | 50,000 | 24.37% | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.01% | 40,694 | - | - | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS V | 0.01% | 737,917 | -2,997 | -0.40% | Feb 29, 2024 |
| Vericimetry Funds | 0.01% | 1,035 | - | - | Mar 31, 2024 |
| EATON VANCE SPECIAL INVESTMENT TRUST | 0.01% | 17,656 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.01% | 216 | 25 | 13.09% | Dec 31, 2023 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.01% | 5,493 | - | - | Feb 29, 2024 |
| GABELLI DIVIDEND & INCOME TRUST | 0.01% | 15,000 | - | - | Dec 29, 2023 |
| ADVISORS' INNER CIRCLE FUND | 0.01% | 208,416 | - | - | Jan 31, 2024 |
| SARATOGA ADVANTAGE TRUST | 0.01% | 511 | - | - | Feb 29, 2024 |
| Pacer Funds Trust | 0.01% | 380,947 | 142,909 | 60.04% | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.01% | 6,171 | - | - | Mar 31, 2024 |
| abrdn Funds | 0.01% | 109,138 | -5,661 | -4.93% | Jan 31, 2024 |
| DEUTSCHE DWS VARIABLE SERIES II | 0.01% | 18,505 | - | - | Mar 31, 2024 |
| Federated Hermes Index Trust | 0.01% | 1,435 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY GROWTH FUNDS, INC. | 0.01% | 866 | - | - | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.01% | 45,812 | - | - | Jan 31, 2024 |
| LKCM Funds | 0.01% | 19,555 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 19,819 | -525 | -2.58% | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 29,743 | -644 | -2.12% | Mar 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.00% | 2,466 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 2,523 | - | - | Mar 31, 2024 |
| CARILLON SERIES TRUST | 0.00% | 224,422 | - | - | Mar 31, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 1,229,247 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.00% | 1,454,427 | -238,018 | -14.06% | Mar 31, 2024 |
| ETFis Series Trust I | 0.00% | 4,818 | 914 | 23.41% | Jan 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.00% | 1,023 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 5,426 | -3,201 | -37.10% | Feb 29, 2024 |
| JNL VARIABLE FUND LLC | 0.00% | 13,013 | -1,509 | -10.39% | Mar 31, 2020 |
| VALUED ADVISERS TRUST | 0.00% | 2,176 | - | - | Jan 31, 2024 |
| Nushares ETF Trust | 0.00% | 16,413 | - | - | Jan 31, 2024 |
| PUTNAM INVESTMENT FUNDS | 0.00% | 11,100 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 484 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 6,501 | 93 | 1.45% | Feb 29, 2024 |
| AMG Funds I | 0.00% | 4,100 | - | - | Jan 31, 2024 |
| HARBOR FUNDS | 0.00% | 46,659 | - | - | Jan 31, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 1,093,000 | - | - | Feb 29, 2024 |
| IndexIQ ETF Trust | 0.00% | 4,423 | -308 | -6.51% | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 159,377 | 7,522 | 4.95% | Jan 31, 2024 |
| Bernstein Fund Inc | 0.00% | 16,147 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 74,216 | 22 | 0.03% | Jan 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 15,642 | 2,135 | 15.81% | Mar 28, 2024 |
| OPTIMUM FUND TRUST | 0.00% | 70,694 | 56,271 | 390.15% | Mar 28, 2024 |
| DELAWARE VIP TRUST | 0.00% | 5,299 | -130 | -2.39% | Mar 28, 2024 |
| HUSSMAN INVESTMENT TRUST | 0.00% | 5,200 | - | - | Dec 31, 2023 |
| OBERWEIS FUNDS | 0.00% | 1,400 | - | - | Mar 31, 2024 |
| UBS FUNDS | 0.00% | 6,409 | - | - | Mar 31, 2024 |
| AMG FUNDS | 0.00% | 35,833 | -13,992 | -28.08% | Mar 28, 2024 |
| North Square Investments Trust | 0.00% | 11,372 | - | - | Jan 31, 2024 |
| SSGA FUNDS | 0.00% | 475 | - | - | Feb 29, 2024 |
| PROFESSIONALLY MANAGED PORTFOLIOS | 0.00% | 75,658 | - | - | Feb 29, 2024 |
| TrimTabs ETF Trust | 0.00% | 652 | 652 | - | Jan 31, 2024 |
| Natixis Funds Trust IV | 0.00% | 299 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 10,671 | - | - | Feb 29, 2024 |
| TIMOTHY PLAN | 0.00% | 3,844 | 513 | 15.40% | Mar 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 25,890 | 14,888 | 135.32% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 156,171 | 6,386 | 4.26% | Feb 29, 2024 |
| Legg Mason ETF Investment Trust | 0.00% | 1,431 | 201 | 16.34% | Mar 31, 2024 |
| Ivy Variable Insurance Portfolios | 0.00% | 15,018 | -788 | -4.99% | Mar 28, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,656 | - | - | Mar 31, 2024 |
| VANGUARD TAX-MANAGED FUNDS | 0.00% | 125,758 | -2,287 | -1.79% | Mar 31, 2024 |
| WILLIAM BLAIR FUNDS | 0.00% | 59,670 | 2,980 | 5.26% | Mar 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 50,361 | - | - | Mar 31, 2024 |
| MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC | 0.00% | 330 | 105 | 46.67% | Sep 30, 2020 |
| Principal Exchange-Traded Funds | 0.00% | 6,922 | -438 | -5.95% | Mar 31, 2024 |
Ligand Pharmaceuticals's largest mutual fund holder by % of total assets is "Virtus Convertible & Income 2024 Target Term Fund", owning 5.00M shares, compromising 2.68% of its total assets.
Ligand Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 174 | -23.01% |
| 31 Mar, 24 | 226 | 4.63% |
| 31 Dec, 23 | 216 | 9.09% |
| 30 Sep, 23 | 198 | -2.94% |
| 30 Jun, 23 | 204 | -3.77% |
| 31 Mar, 23 | 212 | 7.07% |
| 31 Dec, 22 | 198 | -1.98% |
| 30 Sep, 22 | 202 | 5.21% |
| 30 Jun, 22 | 192 | -5.88% |
| 31 Mar, 22 | 204 | -9.73% |
| 31 Dec, 21 | 226 | 3.20% |
| 30 Sep, 21 | 219 | 0.46% |
| 30 Jun, 21 | 218 | -8.79% |
| 31 Mar, 21 | 239 | -4.40% |
| 31 Dec, 20 | 250 | -6.02% |
| 30 Sep, 20 | 266 | -3.62% |
| 30 Jun, 20 | 276 | 0.73% |
| 31 Mar, 20 | 274 | -2.84% |
| 31 Dec, 19 | 282 | -4.73% |
| 30 Sep, 19 | 296 | -9.48% |
| 30 Jun, 19 | 327 | -7.10% |
| 31 Mar, 19 | 352 | -7.85% |
| 31 Dec, 18 | 382 | -4.74% |
| 30 Sep, 18 | 401 | 12.96% |
| 30 Jun, 18 | 355 | 6.29% |
| 31 Mar, 18 | 334 | 8.79% |
| 31 Dec, 17 | 307 | 2.33% |
| 30 Sep, 17 | 300 | 9.89% |
| 30 Jun, 17 | 273 | -0.36% |
| 31 Mar, 17 | 274 | -5.84% |
| 31 Dec, 16 | 291 | 5.43% |
| 30 Sep, 16 | 276 | - |
| 30 Jun, 16 | 276 | 6.15% |
| 31 Mar, 16 | 260 | 9.70% |
| 31 Dec, 15 | 237 | 12.86% |
| 30 Sep, 15 | 210 | -5.83% |
| 30 Jun, 15 | 223 | 16.15% |
| 31 Mar, 15 | 192 | 3.23% |
| 31 Dec, 14 | 186 | 1.64% |
| 30 Sep, 14 | 183 | -9.41% |
| 30 Jun, 14 | 202 | 2.02% |
| 31 Mar, 14 | 198 | 15.79% |
| 31 Dec, 13 | 171 | 23.02% |
| 30 Sep, 13 | 139 | 18.80% |
| 30 Jun, 13 | 117 | 254.55% |
| 31 Mar, 13 | 33 | -8.33% |
| 31 Dec, 12 | 36 | 38.46% |
| 30 Sep, 12 | 26 | -29.73% |
| 30 Jun, 12 | 37 | 2.78% |
| 31 Mar, 12 | 36 | 2.86% |
| 31 Dec, 11 | 35 | 29.63% |
| 30 Sep, 11 | 27 | 8.00% |
| 30 Jun, 11 | 25 | -3.85% |
| 31 Mar, 11 | 26 | 36.84% |
| 31 Dec, 10 | 19 | - |
As of 30 Jun 24, 174 institutions are holding Ligand Pharmaceuticals's shares, representing a decrease of -23.01% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 13,400,782 | -18.30% |
| 31 Mar, 24 | 16,402,720 | 1.60% |
| 31 Dec, 23 | 16,144,849 | 3.07% |
| 30 Sep, 23 | 15,664,612 | 1.30% |
| 30 Jun, 23 | 15,463,388 | 3.14% |
| 31 Mar, 23 | 14,992,496 | 1.98% |
| 31 Dec, 22 | 14,700,842 | -0.90% |
| 30 Sep, 22 | 14,834,606 | -0.62% |
| 30 Jun, 22 | 14,927,295 | -4.47% |
| 31 Mar, 22 | 15,625,098 | -4.00% |
| 31 Dec, 21 | 16,275,939 | -0.94% |
| 30 Sep, 21 | 16,429,927 | 3.17% |
| 30 Jun, 21 | 15,924,954 | 3.30% |
| 31 Mar, 21 | 15,416,644 | -32.46% |
| 31 Dec, 20 | 22,825,363 | -0.12% |
| 30 Sep, 20 | 22,853,114 | 3.60% |
| 30 Jun, 20 | 22,059,510 | -4.05% |
| 31 Mar, 20 | 22,989,645 | 1.28% |
| 31 Dec, 19 | 22,698,443 | -2.66% |
| 30 Sep, 19 | 23,319,894 | -6.49% |
| 30 Jun, 19 | 24,937,961 | -3.71% |
| 31 Mar, 19 | 25,899,265 | -3.51% |
| 31 Dec, 18 | 26,841,179 | 10.28% |
| 30 Sep, 18 | 24,339,231 | -4.87% |
| 30 Jun, 18 | 25,586,152 | 3.55% |
| 31 Mar, 18 | 24,708,257 | 0.09% |
| 31 Dec, 17 | 24,686,306 | 0.26% |
| 30 Sep, 17 | 24,621,560 | -1.62% |
| 30 Jun, 17 | 25,027,550 | 1.30% |
| 31 Mar, 17 | 24,705,639 | -0.37% |
| 31 Dec, 16 | 24,797,137 | -0.14% |
| 30 Sep, 16 | 24,832,348 | 0.66% |
| 30 Jun, 16 | 24,670,506 | -1.89% |
| 31 Mar, 16 | 25,145,501 | 8.60% |
| 31 Dec, 15 | 23,155,263 | 1.96% |
| 30 Sep, 15 | 22,710,550 | 4.92% |
| 30 Jun, 15 | 21,644,606 | -2.91% |
| 31 Mar, 15 | 22,293,717 | 2.87% |
| 31 Dec, 14 | 21,670,953 | -1.27% |
| 30 Sep, 14 | 21,949,993 | 5.37% |
| 30 Jun, 14 | 20,831,923 | -0.14% |
| 31 Mar, 14 | 20,861,003 | 3.41% |
| 31 Dec, 13 | 20,172,566 | 21.68% |
| 30 Sep, 13 | 16,578,455 | 0.71% |
| 30 Jun, 13 | 16,461,528 | 51.82% |
| 31 Mar, 13 | 10,842,896 | -4.93% |
| 31 Dec, 12 | 11,404,935 | 149.60% |
| 30 Sep, 12 | 4,569,210 | -32.50% |
| 30 Jun, 12 | 6,769,103 | 60.32% |
| 31 Mar, 12 | 4,222,308 | 15.57% |
| 31 Dec, 11 | 3,653,545 | -20.99% |
| 30 Sep, 11 | 4,624,196 | -22.07% |
| 30 Jun, 11 | 5,933,727 | 0.90% |
| 31 Mar, 11 | 5,880,988 | 48.83% |
| 31 Dec, 10 | 3,951,534 | - |
Ligand Pharmaceuticals (LGND) has 13.40M shares outstanding as of 30 Jun 24, down -18.30% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 75.57% | 0.84% |
| 31 Mar, 24 | 94.82% | 1.10% |
| 31 Dec, 23 | 92.89% | 1.13% |
| 30 Sep, 23 | 90.67% | 1.10% |
| 30 Jun, 23 | 90.63% | 1.17% |
| 31 Mar, 23 | 87.87% | 1.16% |
| 31 Dec, 22 | 87.15% | 1.13% |
| 30 Sep, 22 | 87.84% | 1.12% |
| 30 Jun, 22 | 88.49% | 1.03% |
| 31 Mar, 22 | 92.87% | 0.98% |
| 31 Dec, 21 | 97.27% | 1.00% |
| 30 Sep, 21 | 98.45% | 1.08% |
| 30 Jun, 21 | 95.59% | 1.09% |
| 31 Mar, 21 | 93.80% | 0.47% |
| 31 Dec, 20 | 141.98% | 0.70% |
| 30 Sep, 20 | 142.10% | 0.75% |
| 30 Jun, 20 | 137.40% | 0.71% |
| 31 Mar, 20 | 139.09% | 0.97% |
| 31 Dec, 19 | 119.50% | 0.77% |
| 30 Sep, 19 | 124.24% | 0.76% |
| 30 Jun, 19 | 127.51% | 0.79% |
| 31 Mar, 19 | 126.67% | 0.78% |
| 31 Dec, 18 | 127.38% | 0.96% |
| 30 Sep, 18 | 115.09% | 0.79% |
| 30 Jun, 18 | 120.62% | 0.89% |
| 31 Mar, 18 | 116.50% | 0.85% |
| 31 Dec, 17 | 116.94% | 0.86% |
| 30 Sep, 17 | 116.85% | 0.82% |
| 30 Jun, 17 | 119.11% | 0.86% |
| 31 Mar, 17 | 117.99% | 0.83% |
| 31 Dec, 16 | 119.04% | 0.84% |
| 30 Sep, 16 | 118.89% | 0.85% |
| 30 Jun, 16 | 118.43% | 0.80% |
| 31 Mar, 16 | 121.43% | 0.90% |
| 31 Dec, 15 | 116.17% | 0.89% |
| 30 Sep, 15 | 114.20% | 0.95% |
| 30 Jun, 15 | 109.73% | 0.85% |
| 31 Mar, 15 | 113.67% | 1.01% |
| 31 Dec, 14 | 106.13% | 0.92% |
| 30 Sep, 14 | 107.51% | 1.07% |
| 30 Jun, 14 | 100.45% | 0.98% |
| 31 Mar, 14 | 101.26% | 1.04% |
| 31 Dec, 13 | 98.68% | 1.49% |
| 30 Sep, 13 | 81.44% | 1.23% |
| 30 Jun, 13 | 81.26% | 2.82% |
| 31 Mar, 13 | 53.71% | 1.66% |
| 31 Dec, 12 | 56.93% | 10.82% |
| 30 Sep, 12 | 22.94% | 1.95% |
| 30 Jun, 12 | 34.28% | 7.47% |
| 31 Mar, 12 | 21.42% | 6.20% |
| 31 Dec, 11 | 18.59% | 3.36% |
| 30 Sep, 11 | 23.51% | 2.58% |
| 30 Jun, 11 | 30.20% | 3.36% |
| 31 Mar, 11 | 29.97% | 7.38% |
| 31 Dec, 10 | 20.15% | - |
As of 30 Jun 24, Ligand Pharmaceuticals is held by 75.57% institutional shareholders, representing a 0.84% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 89 | -10.10% |
| 31 Mar, 24 | 99 | -6.60% |
| 31 Dec, 23 | 106 | 26.19% |
| 30 Sep, 23 | 84 | -17.65% |
| 30 Jun, 23 | 102 | -1.92% |
| 31 Mar, 23 | 104 | - |
| 31 Dec, 22 | 104 | 10.64% |
| 30 Sep, 22 | 94 | 20.51% |
| 30 Jun, 22 | 78 | -9.30% |
| 31 Mar, 22 | 86 | -12.24% |
| 31 Dec, 21 | 98 | 2.08% |
| 30 Sep, 21 | 96 | 4.35% |
| 30 Jun, 21 | 92 | -2.13% |
| 31 Mar, 21 | 94 | -16.07% |
| 31 Dec, 20 | 112 | -5.88% |
| 30 Sep, 20 | 119 | -0.83% |
| 30 Jun, 20 | 120 | 3.45% |
| 31 Mar, 20 | 116 | 26.09% |
| 31 Dec, 19 | 92 | -8.91% |
| 30 Sep, 19 | 101 | -18.55% |
| 30 Jun, 19 | 124 | -26.19% |
| 31 Mar, 19 | 168 | -22.22% |
| 31 Dec, 18 | 216 | 22.03% |
| 30 Sep, 18 | 177 | 8.59% |
| 30 Jun, 18 | 163 | 3.82% |
| 31 Mar, 18 | 157 | -1.88% |
| 31 Dec, 17 | 160 | -2.44% |
| 30 Sep, 17 | 164 | 16.31% |
| 30 Jun, 17 | 141 | 5.22% |
| 31 Mar, 17 | 134 | -3.60% |
| 31 Dec, 16 | 139 | 2.96% |
| 30 Sep, 16 | 135 | -11.18% |
| 30 Jun, 16 | 152 | -3.80% |
| 31 Mar, 16 | 158 | 24.41% |
| 31 Dec, 15 | 127 | 6.72% |
| 30 Sep, 15 | 119 | 7.21% |
| 30 Jun, 15 | 111 | 9.90% |
| 31 Mar, 15 | 101 | 3.06% |
| 31 Dec, 14 | 98 | 6.52% |
| 30 Sep, 14 | 92 | -17.86% |
| 30 Jun, 14 | 112 | -0.88% |
| 31 Mar, 14 | 113 | 1.80% |
| 31 Dec, 13 | 111 | 60.87% |
| 30 Sep, 13 | 69 | -25.00% |
| 30 Jun, 13 | 92 | 338.10% |
| 31 Mar, 13 | 21 | -8.70% |
| 31 Dec, 12 | 23 | 53.33% |
| 30 Sep, 12 | 15 | -37.50% |
| 30 Jun, 12 | 24 | 20.00% |
| 31 Mar, 12 | 20 | -16.67% |
| 31 Dec, 11 | 24 | 60.00% |
| 30 Sep, 11 | 15 | 25.00% |
| 30 Jun, 11 | 12 | -25.00% |
| 31 Mar, 11 | 16 | -15.79% |
| 31 Dec, 10 | 19 | - |
89 institutional shareholders have increased their position in LGND stock as of 30 Jun 24 compared to 99 in the previous quarter (a -10.10% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 52 | -25.71% |
| 31 Mar, 24 | 70 | -4.11% |
| 31 Dec, 23 | 73 | -6.41% |
| 30 Sep, 23 | 78 | 16.42% |
| 30 Jun, 23 | 67 | -6.94% |
| 31 Mar, 23 | 72 | 22.03% |
| 31 Dec, 22 | 59 | -11.94% |
| 30 Sep, 22 | 67 | -10.67% |
| 30 Jun, 22 | 75 | -5.06% |
| 31 Mar, 22 | 79 | -5.95% |
| 31 Dec, 21 | 84 | 18.31% |
| 30 Sep, 21 | 71 | -6.58% |
| 30 Jun, 21 | 76 | -28.30% |
| 31 Mar, 21 | 106 | 15.22% |
| 31 Dec, 20 | 92 | -8.00% |
| 30 Sep, 20 | 100 | -13.79% |
| 30 Jun, 20 | 116 | 3.57% |
| 31 Mar, 20 | 112 | -13.85% |
| 31 Dec, 19 | 130 | - |
| 30 Sep, 19 | 130 | -6.47% |
| 30 Jun, 19 | 139 | 13.01% |
| 31 Mar, 19 | 123 | 29.47% |
| 31 Dec, 18 | 95 | -41.72% |
| 30 Sep, 18 | 163 | 24.43% |
| 30 Jun, 18 | 131 | 3.97% |
| 31 Mar, 18 | 126 | 29.90% |
| 31 Dec, 17 | 97 | 18.29% |
| 30 Sep, 17 | 82 | -3.53% |
| 30 Jun, 17 | 85 | -15.00% |
| 31 Mar, 17 | 100 | 1.01% |
| 31 Dec, 16 | 99 | 2.06% |
| 30 Sep, 16 | 97 | 7.78% |
| 30 Jun, 16 | 90 | 28.57% |
| 31 Mar, 16 | 70 | -10.26% |
| 31 Dec, 15 | 78 | 16.42% |
| 30 Sep, 15 | 67 | -25.56% |
| 30 Jun, 15 | 90 | 50.00% |
| 31 Mar, 15 | 60 | -1.64% |
| 31 Dec, 14 | 61 | 3.39% |
| 30 Sep, 14 | 59 | -7.81% |
| 30 Jun, 14 | 64 | 6.67% |
| 31 Mar, 14 | 60 | 53.85% |
| 31 Dec, 13 | 39 | -18.75% |
| 30 Sep, 13 | 48 | 300.00% |
| 30 Jun, 13 | 12 | 71.43% |
| 31 Mar, 13 | 7 | -22.22% |
| 31 Dec, 12 | 9 | 28.57% |
| 30 Sep, 12 | 7 | 16.67% |
| 30 Jun, 12 | 6 | -14.29% |
| 31 Mar, 12 | 7 | 16.67% |
| 31 Dec, 11 | 6 | -14.29% |
| 30 Sep, 11 | 7 | -22.22% |
| 30 Jun, 11 | 9 | 50.00% |
| 31 Mar, 11 | 6 | - |
| 31 Dec, 10 | - | - |
52 institutional shareholders have reduced their position in LGND stock as of 30 Jun 24 compared to 70 in the previous quarter (a -25.71% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 174 | -23.01% | 13,400,782 | -18.30% | 75.57% | 0.84% | 89 | -10.10% | 52 | -25.71% |
| 31 Mar, 24 | 226 | 4.63% | 16,402,720 | 1.60% | 94.82% | 1.10% | 99 | -6.60% | 70 | -4.11% |
| 31 Dec, 23 | 216 | 9.09% | 16,144,849 | 3.07% | 92.89% | 1.13% | 106 | 26.19% | 73 | -6.41% |
| 30 Sep, 23 | 198 | -2.94% | 15,664,612 | 1.30% | 90.67% | 1.10% | 84 | -17.65% | 78 | 16.42% |
| 30 Jun, 23 | 204 | -3.77% | 15,463,388 | 3.14% | 90.63% | 1.17% | 102 | -1.92% | 67 | -6.94% |
| 31 Mar, 23 | 212 | 7.07% | 14,992,496 | 1.98% | 87.87% | 1.16% | 104 | - | 72 | 22.03% |
| 31 Dec, 22 | 198 | -1.98% | 14,700,842 | -0.90% | 87.15% | 1.13% | 104 | 10.64% | 59 | -11.94% |
| 30 Sep, 22 | 202 | 5.21% | 14,834,606 | -0.62% | 87.84% | 1.12% | 94 | 20.51% | 67 | -10.67% |
| 30 Jun, 22 | 192 | -5.88% | 14,927,295 | -4.47% | 88.49% | 1.03% | 78 | -9.30% | 75 | -5.06% |
| 31 Mar, 22 | 204 | -9.73% | 15,625,098 | -4.00% | 92.87% | 0.98% | 86 | -12.24% | 79 | -5.95% |
| 31 Dec, 21 | 226 | 3.20% | 16,275,939 | -0.94% | 97.27% | 1.00% | 98 | 2.08% | 84 | 18.31% |
| 30 Sep, 21 | 219 | 0.46% | 16,429,927 | 3.17% | 98.45% | 1.08% | 96 | 4.35% | 71 | -6.58% |
| 30 Jun, 21 | 218 | -8.79% | 15,924,954 | 3.30% | 95.59% | 1.09% | 92 | -2.13% | 76 | -28.30% |
| 31 Mar, 21 | 239 | -4.40% | 15,416,644 | -32.46% | 93.80% | 0.47% | 94 | -16.07% | 106 | 15.22% |
| 31 Dec, 20 | 250 | -6.02% | 22,825,363 | -0.12% | 141.98% | 0.70% | 112 | -5.88% | 92 | -8.00% |
| 30 Sep, 20 | 266 | -3.62% | 22,853,114 | 3.60% | 142.10% | 0.75% | 119 | -0.83% | 100 | -13.79% |
| 30 Jun, 20 | 276 | 0.73% | 22,059,510 | -4.05% | 137.40% | 0.71% | 120 | 3.45% | 116 | 3.57% |
| 31 Mar, 20 | 274 | -2.84% | 22,989,645 | 1.28% | 139.09% | 0.97% | 116 | 26.09% | 112 | -13.85% |
| 31 Dec, 19 | 282 | -4.73% | 22,698,443 | -2.66% | 119.50% | 0.77% | 92 | -8.91% | 130 | - |
| 30 Sep, 19 | 296 | -9.48% | 23,319,894 | -6.49% | 124.24% | 0.76% | 101 | -18.55% | 130 | -6.47% |
| 30 Jun, 19 | 327 | -7.10% | 24,937,961 | -3.71% | 127.51% | 0.79% | 124 | -26.19% | 139 | 13.01% |
| 31 Mar, 19 | 352 | -7.85% | 25,899,265 | -3.51% | 126.67% | 0.78% | 168 | -22.22% | 123 | 29.47% |
| 31 Dec, 18 | 382 | -4.74% | 26,841,179 | 10.28% | 127.38% | 0.96% | 216 | 22.03% | 95 | -41.72% |
| 30 Sep, 18 | 401 | 12.96% | 24,339,231 | -4.87% | 115.09% | 0.79% | 177 | 8.59% | 163 | 24.43% |
| 30 Jun, 18 | 355 | 6.29% | 25,586,152 | 3.55% | 120.62% | 0.89% | 163 | 3.82% | 131 | 3.97% |
| 31 Mar, 18 | 334 | 8.79% | 24,708,257 | 0.09% | 116.50% | 0.85% | 157 | -1.88% | 126 | 29.90% |
| 31 Dec, 17 | 307 | 2.33% | 24,686,306 | 0.26% | 116.94% | 0.86% | 160 | -2.44% | 97 | 18.29% |
| 30 Sep, 17 | 300 | 9.89% | 24,621,560 | -1.62% | 116.85% | 0.82% | 164 | 16.31% | 82 | -3.53% |
| 30 Jun, 17 | 273 | -0.36% | 25,027,550 | 1.30% | 119.11% | 0.86% | 141 | 5.22% | 85 | -15.00% |
| 31 Mar, 17 | 274 | -5.84% | 24,705,639 | -0.37% | 117.99% | 0.83% | 134 | -3.60% | 100 | 1.01% |
| 31 Dec, 16 | 291 | 5.43% | 24,797,137 | -0.14% | 119.04% | 0.84% | 139 | 2.96% | 99 | 2.06% |
| 30 Sep, 16 | 276 | - | 24,832,348 | 0.66% | 118.89% | 0.85% | 135 | -11.18% | 97 | 7.78% |
| 30 Jun, 16 | 276 | 6.15% | 24,670,506 | -1.89% | 118.43% | 0.80% | 152 | -3.80% | 90 | 28.57% |
| 31 Mar, 16 | 260 | 9.70% | 25,145,501 | 8.60% | 121.43% | 0.90% | 158 | 24.41% | 70 | -10.26% |
| 31 Dec, 15 | 237 | 12.86% | 23,155,263 | 1.96% | 116.17% | 0.89% | 127 | 6.72% | 78 | 16.42% |
| 30 Sep, 15 | 210 | -5.83% | 22,710,550 | 4.92% | 114.20% | 0.95% | 119 | 7.21% | 67 | -25.56% |
| 30 Jun, 15 | 223 | 16.15% | 21,644,606 | -2.91% | 109.73% | 0.85% | 111 | 9.90% | 90 | 50.00% |
| 31 Mar, 15 | 192 | 3.23% | 22,293,717 | 2.87% | 113.67% | 1.01% | 101 | 3.06% | 60 | -1.64% |
| 31 Dec, 14 | 186 | 1.64% | 21,670,953 | -1.27% | 106.13% | 0.92% | 98 | 6.52% | 61 | 3.39% |
| 30 Sep, 14 | 183 | -9.41% | 21,949,993 | 5.37% | 107.51% | 1.07% | 92 | -17.86% | 59 | -7.81% |
| 30 Jun, 14 | 202 | 2.02% | 20,831,923 | -0.14% | 100.45% | 0.98% | 112 | -0.88% | 64 | 6.67% |
| 31 Mar, 14 | 198 | 15.79% | 20,861,003 | 3.41% | 101.26% | 1.04% | 113 | 1.80% | 60 | 53.85% |
| 31 Dec, 13 | 171 | 23.02% | 20,172,566 | 21.68% | 98.68% | 1.49% | 111 | 60.87% | 39 | -18.75% |
| 30 Sep, 13 | 139 | 18.80% | 16,578,455 | 0.71% | 81.44% | 1.23% | 69 | -25.00% | 48 | 300.00% |
| 30 Jun, 13 | 117 | 254.55% | 16,461,528 | 51.82% | 81.26% | 2.82% | 92 | 338.10% | 12 | 71.43% |
| 31 Mar, 13 | 33 | -8.33% | 10,842,896 | -4.93% | 53.71% | 1.66% | 21 | -8.70% | 7 | -22.22% |
| 31 Dec, 12 | 36 | 38.46% | 11,404,935 | 149.60% | 56.93% | 10.82% | 23 | 53.33% | 9 | 28.57% |
| 30 Sep, 12 | 26 | -29.73% | 4,569,210 | -32.50% | 22.94% | 1.95% | 15 | -37.50% | 7 | 16.67% |
| 30 Jun, 12 | 37 | 2.78% | 6,769,103 | 60.32% | 34.28% | 7.47% | 24 | 20.00% | 6 | -14.29% |
| 31 Mar, 12 | 36 | 2.86% | 4,222,308 | 15.57% | 21.42% | 6.20% | 20 | -16.67% | 7 | 16.67% |
| 31 Dec, 11 | 35 | 29.63% | 3,653,545 | -20.99% | 18.59% | 3.36% | 24 | 60.00% | 6 | -14.29% |
| 30 Sep, 11 | 27 | 8.00% | 4,624,196 | -22.07% | 23.51% | 2.58% | 15 | 25.00% | 7 | -22.22% |
| 30 Jun, 11 | 25 | -3.85% | 5,933,727 | 0.90% | 30.20% | 3.36% | 12 | -25.00% | 9 | 50.00% |
| 31 Mar, 11 | 26 | 36.84% | 5,880,988 | 48.83% | 29.97% | 7.38% | 16 | -15.79% | 6 | - |
| 31 Dec, 10 | 19 | - | 3,951,534 | - | 20.15% | - | 19 | - | - | - |
Ligand Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Ligand Pharmaceuticals's stock was made by Korenberg Matthew E on Aug 13 2024, selling 18,245 shares at $98.50 per share (valued at $1.80M). The last insider buy of LGND was made by Davis Todd C on Aug 09 2024, buying 2,500 shares at $97.39 per share (worth $243.48K).
Ligand Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | - | - |
| Q2 2024 | 25 | 16 | 156.25% |
| Q1 2024 | 17 | 16 | 106.25% |
| Q4 2023 | 1 | 3 | 33.33% |
| Q3 2023 | 3 | 1 | 300.00% |
| Q2 2023 | 15 | 8 | 187.50% |
| Q1 2023 | 8 | 3 | 266.67% |
| Q4 2022 | 31 | 43 | 72.09% |
| Q3 2022 | - | 3 | - |
| Q2 2022 | 39 | 5 | 780.00% |
| Q1 2022 | 9 | 22 | 40.91% |
| Q4 2021 | 3 | 6 | 50.00% |
| Q3 2021 | 4 | 3 | 133.33% |
| Q2 2021 | 19 | 5 | 380.00% |
| Q1 2021 | 28 | 41 | 68.29% |
| Q4 2020 | 4 | 4 | 100.00% |
| Q3 2020 | 6 | 8 | 75.00% |
| Q2 2020 | 18 | 1 | 1800.00% |
| Q1 2020 | 14 | 18 | 77.78% |
| Q4 2019 | 11 | 9 | 122.22% |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Ligand Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | - | - |
| Q2 2024 | - | 9 | - |
| Q1 2024 | - | 2 | - |
| Q4 2023 | - | - | - |
| Q3 2023 | 1 | - | - |
| Q2 2023 | - | 4 | - |
| Q1 2023 | - | 1 | - |
| Q4 2022 | - | 3 | - |
| Q3 2022 | - | 3 | - |
| Q2 2022 | 1 | 2 | 50.00% |
| Q1 2022 | - | 1 | - |
| Q4 2021 | - | 3 | - |
| Q3 2021 | - | 1 | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 8 | - |
| Q4 2020 | 1 | - | - |
| Q3 2020 | - | 2 | - |
| Q2 2020 | - | 1 | - |
| Q1 2020 | - | 2 | - |
| Q4 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 1 open market buy trades and 0 open market sell trades of Ligand Pharmaceuticals's stocks.
Ligand Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| AKRO | Akero Therapeutics, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| VRDN | Viridian Therapeutics, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| RCUS | Arcus Biosciences, Inc. |
| BPMC | Blueprint Medicines Corporation |
| BGNE | BeiGene, Ltd. |
| RLAY | Relay Therapeutics, Inc. |
| LYEL | Lyell Immunopharma, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| PASG | Passage Bio, Inc. |
| ORIC | ORIC Pharmaceuticals, Inc. |
| CRNX | Crinetics Pharmaceuticals, Inc. |
| ANNX | Annexon, Inc. |
| ASND | Ascendis Pharma A/S |
| DSGN | Design Therapeutics, Inc. |
| GPCR | Structure Therapeutics Inc. |
| ETNB | 89bio, Inc. |
| CYTK | Cytokinetics, Incorporated |
LGND Ownership FAQ
Who Owns Ligand Pharmaceuticals?
Ligand Pharmaceuticals is owned by institutional shareholders (75.57%), insiders (2.14%), and public (22.29%). The largest institutional shareholder of Ligand Pharmaceuticals is BLACKROCK INC. (16.19% of total shares) and the top mutual fund owner is Virtus Convertible & Income 2024 Target Term Fund (2.68% of total shares).
Who are the major institutional shareholders of Ligand Pharmaceuticals?
Ligand Pharmaceuticals's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, MACQUARIE GROUP LTD, and DIMENSIONAL FUND ADVISORS LP. The top five shareholders own together 42.20% of the company's share outstanding.
How many Ligand Pharmaceuticals shareholders are there?
As of Jun 2024, there are 174 institutional shareholders of Ligand Pharmaceuticals.
What percentage of Ligand Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC owns 2.87M shares of Ligand Pharmaceuticals, representing 16.19% of the company's total shares outstanding, valued at $241.95M (as of Jun 2024).
What percentage of Ligand Pharmaceuticals is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 1.93M shares of Ligand Pharmaceuticals (LGND), compromising 10.87% of the company, valued at $162.36M.
What percentage of Ligand Pharmaceuticals is owned by JANUS HENDERSON GROUP PLC?
JANUS HENDERSON GROUP PLC is the third largest holder of Ligand Pharmaceuticals. The company owns 1.01M of the company's shares outstanding (worth $84.99M).